{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:16:32Z","timestamp":1783397792874,"version":"3.54.6"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2025YC23"],"award-info":[{"award-number":["2025YC23"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2023IR45"],"award-info":[{"award-number":["2023IR45"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7244422"],"award-info":[{"award-number":["7244422"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271771"],"award-info":[{"award-number":["82271771"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101150","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:40:43Z","timestamp":1774136443000},"page":"101150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term Outcomes of Toxicities and Disease Control Following Postoperative Moderately Hypofractionated Radiotherapy in High-Risk Prostate Cancer: Results of a Prospective Study"],"prefix":"10.1016","volume":"59","author":[{"given":"Xue-Ying","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Bin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Shu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101150_b0005","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.296.19.2329","article-title":"Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial","volume":"296","author":"Thompson","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ctro.2026.101150_b0010","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101150_b0015","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101150_b0020","unstructured":"NCCN Clinical Practice Guidelines in Oncology-Prostate Cancer (Version 1.2025)."},{"key":"10.1016\/j.ctro.2026.101150_b0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaoncol.2023.7291","article-title":"Noninferiority of Hypofractionated vs conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: the NRG-GU003 phase 3 Randomized Clinical Trial","volume":"10","author":"Buyyounouski","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101150_b0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/COC.0b013e3181f946dc","article-title":"Toxicity associated with postoperative radiation therapy for prostate cancer","volume":"34","author":"Iyengar","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101150_b0035","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/JU.0000000000002443","article-title":"Hematuria following Post-Prostatectomy Radiotherapy: Incidence increases with Long-Term Followup","volume":"207","author":"Turchan","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.ctro.2026.101150_b0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijrobp.2015.11.025","article-title":"Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer","volume":"94","author":"Lewis","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101150_b0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2008.08.002","article-title":"RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer","volume":"74","author":"Lawton","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101150_b0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101150_b0055","article-title":"Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced image Guidance","volume":"15","author":"Laughlin","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101150_b0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000000295","article-title":"Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO\/AUA Guideline Amendment 2018-2019","volume":"202","author":"Pisansky","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.ctro.2026.101150_b0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.eururo.2014.06.012","article-title":"Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients","volume":"66","author":"Cozzarini","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2026.101150_b0070","first-page":"1221","article-title":"Postoperative Hypofractionated Radiation Therapy in Prostate Carcinoma: a Systematic Review","volume":"38","author":"Siepe","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctro.2026.101150_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244227","article-title":"Evidences on the use of Hypofractionation in Postoperative\/Salvage Radiotherapy for Prostate Cancer: Systematic Review of the Literature and recent Developments","volume":"16","author":"Roukoz","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101150_b0080","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2023.04.032","article-title":"Salvage Radiation Therapy after Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial","volume":"117","author":"Petersen","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101150_b0085","article-title":"Outcome and Toxicity of Moderately Hypofractionated Post-Prostatectomy Radiotherapy: a Retrospective Study","volume":"13","author":"Vilella","year":"2025","journal-title":"Med Sci (basel)"},{"key":"10.1016\/j.ctro.2026.101150_b0090","first-page":"57","article-title":"Challenges and Opportunities in Radiation-induced Hemorrhagic Cystitis","volume":"18","author":"Zwaans","year":"2016","journal-title":"Rev Urol"},{"key":"10.1016\/j.ctro.2026.101150_b0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2018.02.002","article-title":"Postoperative Radiation Therapy for Prostate Cancer: Comparison of conventional Versus Hypofractionated Radiation Regimens","volume":"101","author":"Tandberg","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101150_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/03915603221093733","article-title":"Effect of endoscopic urethral procedures applied after robotic radical prostatectomy on urinary incontinence: a prospective cohort pilot study","volume":"90","author":"Unal","year":"2023","journal-title":"Urologia"},{"key":"10.1016\/j.ctro.2026.101150_b0105","article-title":"Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","volume":"352","author":"Wallis","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ctro.2026.101150_b0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101150_b0115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101150_b0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.radonc.2022.03.006","article-title":"Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: a cohort study with meta-analysis","volume":"171","author":"Viani","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101150_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102102","article-title":"10-yr results of Moderately Hypofractionated Postoperative Radiotherapy for Prostate Cancer Focused on Treatment Related Toxicity","volume":"22","author":"Castelluccia","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ctro.2026.101150_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00432-021-03816-y","article-title":"Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes","volume":"148","author":"Ferrera","year":"2022","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:40:12Z","timestamp":1783395612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S2405630826000455"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101150","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Outcomes of Toxicities and Disease Control Following Postoperative Moderately Hypofractionated Radiotherapy in High-Risk Prostate Cancer: Results of a Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101150"}}